Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Aims

To investigate the radiological characteristics of the PHNENs on CT and MRI and improve the understanding of the image manifestations and preoperative diagnosis of the disease.

Background

Primary hepatic neuroendocrine neoplasms (PHNENs) are rare diseases, and most of the relevant studies are case reports. Characterized by no specific clinical symptoms, PHNENs not only have a low preoperative diagnosis rate with great difficulty in early diagnosis but are frequently misdiagnosed as primary hepatic cancer.

Objective

15 PHNEN patients were enrolled, with 10 cases in the G2 stage and 5 cases in the G3 stage.

Methods

The imaging and clinicopathological information of 15 patients pathologically diagnosed with PHNENs was retrospectively reviewed.

Results

The average age of the patients enrolled was 46.14±18.24 years, and the average tumor size was 91.00±61.17 mm. 13 cases showed nodules or masses, 8 cases were located in the periphery of the liver, showing capsule depression and subcapsular effusion signs. CT enhanced scan showed heterogeneous and obvious enhancement in 9 arterial-phase cases, 2 cases in arterial and portal venous phases both saw mild enhancement; the enhancement degree of lesions in the G2 stage in the arterial phase was significantly higher than in the G3 stage. Gd-EOB-DTPA dynamic enhanced MRI was conducted on 3 cases, and scattered lesions with heterogeneous and slight hyperintensity were observed in the hepatobiliary-specific lesions. Image manifestations showed diffuse lesions in 2 cases, with heterogeneous enhancement in the arterial phase and decreased enhancement in the portal venous phase by the dynamic enhanced scan.

Conclusion

PHNENs were the imaging characteristics of PHNENs. The CT-enhanced scanning during the arterial phase may provide a certain reference for pathological grading (G2 and G3 grades). Gd-EOB-DTPA-enhanced MRI is helpful for PHNEN diagnosis.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056243238231031031426
2024-01-01
2025-09-08
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIR-20-E15734056243238.html?itemId=/content/journals/cmir/10.2174/0115734056243238231031031426&mimeType=html&fmt=ahah

References

  1. ParkC.H. ChungJ.W. JangS.J. ChungM.J. BangS. ParkS.W. SongS.Y. ChungJ.B. ParkJ.Y. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.J. Gastroenterol. Hepatol.20122781306131110.1111/j.1440‑1746.2012.07117.x22414232
    [Google Scholar]
  2. Gastrointestinal Hormone and Neuroendocrine Neoplasm GroupChineseSociety of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm (2020, Guangzhou).Chin J Dig2021412768710.3760/cma.j.cn311367‑20210104‑00007
    [Google Scholar]
  3. HanD XuX CT features in predicting the pathological classification and prognosis in gastroenteric neuroendocrine neoplasm.Journal of Practical Radiology201733656657010.3969/j.issn.1002‑1671.2017.06.013
    [Google Scholar]
  4. CivesM. StrosbergJ.R. Gastroenteropancreatic neuroendocrine tumors.CA Cancer J. Clin.201868647148710.3322/caac.2149330295930
    [Google Scholar]
  5. WangH. HeY. LiuS. Diffuse primary neuroendocrine tumor of the liver: A case report.Radiol. Prat.201934559159210.13609/j.cnki.1000‑0313.2019.05.024
    [Google Scholar]
  6. MengX.F. PanY.W. WangZ.B. DuanW.D. Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: A case report and literature review.World J. Gastroenterol.201824242640264610.3748/wjg.v24.i24.264029962820
    [Google Scholar]
  7. ShiD. MaL. LiH. Clinical characteristics and imaging features of primary hepatic neuroendocrine neoplasm.Chinese J Magn Reson Imag202011865565810.12015/issn.1674‑8034.2020.08.012
    [Google Scholar]
  8. LvY. HuangC. XuH. HanX. ZhangL. MaoW. JiY. JinD. LouW. XuX. Clinicopathological Characteristics of the primary and metastatic Hepatic Neuroendocrine Tumors and the relevant Prognosis-Related Factors: A Retrospective Study of 81 Cases in a Single Chinese Center.J. Cancer20189347948710.7150/jca.2215729483952
    [Google Scholar]
  9. PiaoY. WangH. MaL. MRI features of primary hepatic neuroendocrine tumor.Zhonghua Fang She Xue Za Zhi201852212513010.3760/cma.j.issn.1005‑1201.2018.02.009
    [Google Scholar]
  10. WangL. JiangT. Primary hepatic neuroendocrine tumor: The radiologic features and correlation with pathology.Journal of Practical Radiology20173371029103210.3969/j.issn.1002‑1671.2017.07.012
    [Google Scholar]
  11. LiR.K. ZhaoJ. RaoS.X. ChenC.Z. ZengM.S. QiangJ.W. Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging.Abdom. Imaging20133861269127610.1007/s00261‑013‑0029‑123942951
    [Google Scholar]
  12. LiuG. HuanY. GaoY. The study of the diagnosis value of multi spiral CT and MRI on pancreatic neuroendocrine tumor.Journal of Practical Radiology202171103110710.3969/j.issn.1002‑1671.2021.07.014
    [Google Scholar]
  13. FujitaN. NishieA. AsayamaY. IshigamiK. UshijimaY. KakiharaD. NakayamaT. MoritaK. IshimatsuK. HondaH. Hyperintense liver masses at hepatobiliary phase gadoxetic acid–enhanced MRI: Imaging appearances and clinical importance.Radiographics2020401729410.1148/rg.202019003731834849
    [Google Scholar]
  14. RaoY. WangX. ZhangH. Clinical and imaging manifestations of primary hepatic neuroendocrine carcinoma.Journal of Medical Theory and Practice202033233997399910.19381/j.issn.1001‑7585.2020.23.060
    [Google Scholar]
  15. WangL.X. LiuK. LinG.W. JiangT. Primary hepatic neuroendocrine tumors: Comparing CT and MRI features with pathology.Cancer Imaging20151511310.1186/s40644‑015‑0046‑026272674
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056243238231031031426
Loading
/content/journals/cmir/10.2174/0115734056243238231031031426
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test